- Home
- MMLP vs CADL Comparison
MMLP vs CADL Comparison
Compare MMLP & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- CADL
- Stock Information
- Founded
- MMLP 2002
- CADL 1999
- Country
- MMLP United States
- CADL United States
- Employees
- MMLP N/A
- CADL N/A
- Industry
- MMLP Oil Refining/Marketing
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- MMLP Energy
- CADL Health Care
- Exchange
- MMLP Nasdaq
- CADL Nasdaq
- Market Cap
- MMLP 155.2M
- CADL 159.1M
- IPO Year
- MMLP 2002
- CADL 2021
- Fundamental
- Price
- MMLP $4.01
- CADL $6.56
- Analyst Decision
- MMLP
- CADL Strong Buy
- Analyst Count
- MMLP 0
- CADL 1
- Target Price
- MMLP N/A
- CADL $11.00
- AVG Volume (30 Days)
- MMLP 90.8K
- CADL 8.6M
- Earning Date
- MMLP 02-12-2025
- CADL 11-14-2024
- Dividend Yield
- MMLP 0.50%
- CADL N/A
- EPS Growth
- MMLP N/A
- CADL N/A
- EPS
- MMLP 0.11
- CADL N/A
- Revenue
- MMLP $717,396,000.00
- CADL N/A
- Revenue This Year
- MMLP N/A
- CADL N/A
- Revenue Next Year
- MMLP $0.80
- CADL N/A
- P/E Ratio
- MMLP $37.37
- CADL N/A
- Revenue Growth
- MMLP N/A
- CADL N/A
- 52 Week Low
- MMLP $2.04
- CADL $1.02
- 52 Week High
- MMLP $4.13
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- MMLP 57.65
- CADL 55.25
- Support Level
- MMLP $3.98
- CADL $5.90
- Resistance Level
- MMLP $4.01
- CADL $7.28
- Average True Range (ATR)
- MMLP 0.02
- CADL 1.34
- MACD
- MMLP -0.00
- CADL 0.20
- Stochastic Oscillator
- MMLP 75.00
- CADL 22.09
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.